自2006年起，港大/瑪麗醫院已獲NMPA認證六個臨床專業(包括心血管、內分泌及代謝學、血液及骨髓移稙、肝膽胰外科及肝臟移稙、婦產及生育調節及呼吸)進行藥物臨床試驗。隨著NMPA於2016年7月給予香港大學一期臨床試驗病房及額外七個臨床專業(包括免疫、腸胃及肝臟內科、腎病、神經內科、腫瘤、骨科及兒科)的新認證，港大/瑪麗醫院現共獲NMPA認證14個範疇。

自2006年起，港大/玛丽医院已获NMPA认证六个临床专业(包括心血管、内分泌及代谢学、血液及骨髓移稙、肝胆胰外科及肝脏移稙、妇产及生育调节及呼吸)进行药物临床试验。随着NMPA于2016年7月给予香港大学一期临床试验病房及额外七个临床专业(包括免疫、肠胃及肝脏内科、肾病、神经内科、肿瘤、骨科及儿科)的新认证，港大/玛丽医院现共获NMPA认证14个范畴。

Since 2006, HKU/QMH has been accredited by the National Medical Products Administration (NMPA, previously called China Food and Drug Administration) for conducting clinical drug trials in six clinical specialties (including cardiology, endocrinology & metabolism, haematology & bone marrow transplantation, hepatobiliary & pancreatic surgery/liver transplantation, obstetrics & gynaecology, and respiratory medicine). With the new accreditation for the HKU Phase 1 Clinical Trials Centre and seven additional clinical specialties in July 2016 (including clinical immunology, gastroenterology and hepatology, nephrology, neurology, oncology, orthopaedics & traumatology, and paediatrics & adolescent medicine), HKU/QMH now is accredited by the NMPA in a total of 14 areas.

香港大學一期臨床試驗病房的認證尤關重要，因國內暫無一期病房能取得此官方認證。

香港大学一期临床试验病房的认证尤关重要，因国内暂无一期病房能取得此官方认证。

The accreditation for the HKU Phase 1 Clinical Trials Centre is of exceptional importance as there was no official accreditation for any phase 1 centre in China.